Medtech Webinar

Funding Is Where Most MedTech Startups Stall

Funding Is Where Most MedTech Startups Stall

Founders often build their medical devices in the early stage using personal capital or loans, but without a clear funding strategy, investors won’t invest. Curious about what investors want?

Medtech Failures

Are you sure your startup is using its capital the right way?

Many founders run out of cash before fundraising because they fail to balance product development with commercialization. No revenue no runway. Shut down.

3-5 times chance
of Series A funding for startups with a clear reimbursement strategy
Startups with a reimbursement plan attract investors by showing reduced risk and quicker revenue paths.
12–18 months
time needed to rebuild and re-pitch
Without early reimbursement planning, startups face costly delays, often requiring strategic resets before regaining investor traction.
$2M-$5M
is the average R&D cost for developing a Class II medical device
However, >70% of startups burn early capital on R&D without a clear plan for regulatory, testing, or GTM.
$500K–$1M lost per month
in revenue from launch delays
Being late to market means competitors capture mindshare first, leaving little room for differentiation.
As funding requires more than a great product, aligning goals with TRL stages helps founders show real progress and build investor trust.

What is TRL?

NASA-Verified Definition of Technical Readiness Levels (TRL)

Technology Readiness Levels (TRL) are a type of measurement system used to assess the maturity level of a particular technology.

Each technology project is evaluated against the parameters for each technology level and is then assigned a TRL rating based on the projects progress.

There are nine technology readiness levels. TRL 1 is the lowest and TRL 9 is the highest.

Technology Readiness Levels by NASA
Technology Readiness Levels - NASA

Who we are?

We are ITR.
A technical partner built for MedTech.

We help MedTech startups turn concepts into clinically validated, investor-ready products.

Concept to TRL 3-4
We help you build what’s fundable from the ground up.
  • System architecture (HW-FW-App-Cloud)

  • Rapid PoC development

  • Early TRL mapping and risk visibility

So your prototype aligns with investor logic not just engineering goals.
PoC to TRL 5-6
We structure your build to meet funding and regulatory checkpoints.
  • IEC 62304 firmware, HIPAA data strategy

  • ISO 13485-lite design control

  • Weekly sprints, documented milestones

So you can show progress investors trust and pitch with proof.
Funding Readiness
We help you speak the language of investors-backed by execution.
  • TRL-aligned roadmap + milestone forecast

  • Investor-grade dossier: use case, reimbursement, risk logic

  • Pitch support: technical narrative review

So you’re not just convincing - they’re confident.
Two ITR leads and two partners are pictured in a collaborative development setting; one ITR lead engages with a partner in front of a screen displaying ITR and "mjn-neuro" epilepsy system project details.
ITR VN's "Wearable Technologies" booth at MEDICA 2024, a trade fair for medical technology & healthcare in Düsseldorf, Germany, with attendees in the foreground.
Four ITR lead members stand in front of the Impact Technical Resources "Wearable Medical Devices Design & Engineering" exhibition booth.
Six people attend a meeting in an ITR Vietnam office, where a screen displays "WELCOME CDTI INNOVATION". Key participants include two ITR leads, an ITR business development lead, and two partners from CDTI Innovation.
An ITR lead explains wearable medical device design and engineering to a visitor at the Impact Technical Resources exhibition booth, with a display detailing their expertise.
Two ITR leads and two partners pose in front of the illuminated "ITR Impact Technical Resources" office logo.

What can MedTech founders actually gain from this event?

Understand What Investors Want
Clarify what makes a prototype fundable by understanding technical clinical and regulatory benchmarks that matter to investors.
Strategize Your Product Pitch
Position your product more strategically by learning how to frame your roadmap and risks in investor language.
Connect With Industry Leaders
Connect with 20+ relevant attendees including VCs founders and MedTech decision makers.

Event Agenda

Explore the Funding Readiness for MedTech Startups agenda

Streaming live on Microsoft Teams - July 25, 2025

14:00 (UTC +1 - Berlin/Madrid) · 19:00 (UTC +7 - Vietnam)

14:00
5 mins
Greeting & Welcome Guest
Mr. Hoang Pham - Head of Business Development of ITR
14:05
15 mins
Introduction
Sets the stage with an overview of ITR’s work in MedTech and explains why aligning product maturity with investor expectations is still a major barrier for many startups.
Mr. Hoang Pham - Head of Business Development of ITR
14:20
10 mins
Key Note 1
With decades leading MedTech development from R&D to mass production, Dr. Andreas Mitterer shares what often breaks between “working prototype” and “fundable product.” A grounded keynote to reframe how early-stage teams define readiness.
Dr. Andreas Mitterer - Founder of Mitterer Technology
14:30
10 mins
Key Note 2
What gives investors confidence in early stage MedTech founders, how they evaluate regulatory clarity, clinical traction, realistic burn rates, and why some technically strong teams still get passed. A rare chance to understand what truly matters in the first 24 months.
Ms. Beatriz Plaza Marin - Investment Analyst of CRB Health Tech SGEIC
14:40
25 mins
Panel Discussion
Opens up the real conversation between founders and investors, offering practical insight into what makes a MedTech product truly fundable. A must-attend for early-stage teams looking to align with what VCs actually expect.
Mr. Hoang Pham - Moderator
Ms. Beatriz Plaza Marin - Investment Analyst of CRB Health Tech SGEIC
Dr. Andreas Mitterer - Founder of Mitterer Technology
Ms. Maria Ripoll Bartrolí - Head of Open Innovation of Barcelona Health Hub
15:05
20 mins
Q&A
Mr. Hoang Pham - Head of Business Development of ITR
Ms. Beatriz Plaza Marin - Investment Analyst of CRB Health Tech SGEIC
Dr. Andreas Mitterer - Founder of Mitterer Technology
Ms. Maria Ripoll Bartrolí - Head of Open Innovation of Barcelona Health Hub
15:25
5 mins
Closing
Mr. Hoang Pham - Head of Business Development of ITR

Meet Our Speakers

What Funding Readiness Really Means in MedTech

Image of ITR Webinar Speaker - Duc Hoang Pham
Mr. Hoang Pham
Head of Business Development of ITR
Mr. Hoang Pham is a Digital Technology Consultant with over 15 years experience advancing medical devices and digital health solutions across the EU, US and APAC. As Head of Business Development at ITR, he spearheads initiatives from early concept design through manufacturing-ready rollout, specializing in wearable technologies, biosensors and diagnostic platforms.
He guides MedTech startups and OEMs through product development, regulatory navigation and commercialization strategy positioning him as a trusted partner for founders and investors seeking faster, safer market entry. Day to day, Hoang collaborates with R&D teams, executives and product managers to refine concepts, define technical requirements and enforce compliance with ISO 14971 (risk management), IEC 62304 (medical software) and FHIR (interoperability).
He also supports regulatory pathways such as FDA Class III submissions and De Novo applications, designs CPT reimbursement strategies and oversees CAPA processes to uphold quality and regulatory standards.
View more
Image of ITR Webinar Speaker - Andreas Mitterer
Dr. Andreas Mitterer
Founder of Mitterer Technologies
Dr. Andreas Mitterer is a MedTech development leader with over 20 years of experience turning complex healthcare innovations into commercially viable, regulatory-compliant products. His expertise spans the entire product lifecycle—from concept and prototyping to industrialization, mass production, and post-market support.
As VP of R&D at Implantica, he led the development of active implant systems combining biosignal sensing, electrostimulation, wireless power, and remote programming. He directed cross-functional teams across Europe and Asia, aligning technical execution with market and regulatory needs.
Earlier, at Flex (Flextronics), he oversaw product design and scale-up, ensuring design-for-manufacturing, supplier integration, and quality. At MED-EL, he led R&D for implantable systems, including hardware, firmware, and communications—while managing regulatory engagements.
Dr. Mitterer holds patents in implant telemetry and wireless energy transfer. With a background in engineering physics and systems thinking, he enables MedTech companies to develop reliable, manufacturable products ready for global markets.
View more
Image of ITR Webinar Speaker - Beatriz Plaza Marin
Ms. Beatriz Plaza Marin
Investment Analyst of CRB Health Tech SGEIC
Ms. Beatriz Plaza Marin combines biomedical engineering and pharmaceutical science, focusing on translating deep-tech discoveries into market-ready solutions.
At Medtronic, she spent over five years managing go-to-market campaigns for surgical technologies, coordinating product launches and stakeholder engagement across regions. Currently a strategic investor at CRB Health Tech, she evaluates early-stage digital health and therapeutic platforms, guiding their development and commercialization strategies.
Her background enables her to analyze technical feasibility alongside market viability, structuring plans that move concepts from prototype through regulatory review to adoption. She has worked with cross-disciplinary teams R&D, regulatory, marketing to integrate scientific rigor with business objectives. By aligning project milestones with commercial benchmarks, Ms. Plaza Marin supports scalable healthcare innovations without superfluous promotion.
View more
Image of ITR Webinar Speaker - Maria Ripoll Bartrolí
Ms. Maria Ripoll Bartrolí
Head of Open Innovation of Barcelona Health Hub
Ms. Maria Ripoll Bartrolí serves as Head of Open Innovation at Barcelona & Madrid Health Hub, a non-profit association accelerating digital health innovation across 500+ members including startups, healthcare institutions, universities, corporations and investors. In this capacity, she cultivates cross-sector alliances, guiding early-stage ventures through capital introduction, regulatory navigation and market access throughout Europe.
She holds a Master’s in Public Policy Analysis from the Universitat de Barcelona, where she specialized in regulatory frameworks, gender-inclusive legal perspectives and social-impact policy design. Earlier, she earned a Bachelor’s in International Relations with a focus on European policy and MENA geopolitics from Blanquerna – Universitat Ramon Llull and expanded her regional studies at Saint Joseph University of Beirut.
Leveraging expertise in policy research, gender studies and stakeholder engagement, Ms. Ripoll Bartrolí aligns project milestones with both technical requirements and business objectives to support scalable healthcare solutions.
View more

Register Now

Join our Free Exclusive MedTech Event packed with insights and built for global impact

Special Offer

Applicable for potential MedTech startups to gain
50hrs
free technical
consultation
from our senior medical device experts.
Notice: Only 5 founder-led projects will be selected, following a rigorous review by our in-house evaluators.

Explore MOre InSights

Strategic insight meets real-world impact in Medtech

From funding frameworks to international partnerships, we’re here to support your innovative Medtech products.

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.